102 related articles for article (PubMed ID: 2292763)
1. Finite dose percutaneous drug absorption: theory and its application to in vitro timolol permeation.
Kubota K; Yamada T
J Pharm Sci; 1990 Nov; 79(11):1015-9. PubMed ID: 2292763
[TBL] [Abstract][Full Text] [Related]
2. A random walk method for percutaneous drug absorption pharmacokinetics: application to repeated administration of a therapeutic timolol patch.
Kubota K; Koyama E; Yasuda K
J Pharm Sci; 1991 Aug; 80(8):752-6. PubMed ID: 1791535
[TBL] [Abstract][Full Text] [Related]
3. Dual sorption model for the nonlinear percutaneous permeation kinetics of timolol.
Kubota K; Koyama E; Twizell EH
J Pharm Sci; 1993 Dec; 82(12):1205-8. PubMed ID: 8308696
[TBL] [Abstract][Full Text] [Related]
4. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
Simon L; Loney NW
Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of β-blocker gel and effect of dosing volume for topical delivery.
Zhang Q; Chantasart D; Li SK
J Pharm Sci; 2015 May; 104(5):1721-31. PubMed ID: 25694227
[TBL] [Abstract][Full Text] [Related]
6. Water-activated, pH-controlled patch in transdermal administration of timolol. I. Preclinical tests.
Sutinen R; Paronen P; Urtti A
Eur J Pharm Sci; 2000 Jul; 11(1):19-24. PubMed ID: 10913749
[TBL] [Abstract][Full Text] [Related]
7. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
George K
Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin.
Soni S; Dixit VK
Pharmazie; 1994 Jan; 49(1):73-4. PubMed ID: 8140139
[No Abstract] [Full Text] [Related]
9. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
Fatouros DG; Bouwstra JA
J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
Simon L; Ospina J
Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of timolol by electroporation through human skin.
Denet AR; Préat V
J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
[TBL] [Abstract][Full Text] [Related]
12. [Transdermal properties of timolol and factors affecting its permeability in vitro].
Xu YZ; Xu HN
Yao Xue Xue Bao; 1992; 27(6):467-71. PubMed ID: 1442076
[TBL] [Abstract][Full Text] [Related]
13. A simplified approach for estimating skin permeation parameters from in vitro finite dose absorption studies.
Lehman PA
J Pharm Sci; 2014 Dec; 103(12):4048-4057. PubMed ID: 25324199
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic effects of transdermal bupranolol and timolol in vivo: comparison of microemulsions and matrix patches as vehicle.
Kemken J; Ziegler A; Müller BW
Methods Find Exp Clin Pharmacol; 1991 Jun; 13(5):361-5. PubMed ID: 1921573
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous absorption: a single-layer model.
Kubota K; Sznitowska M; Maibach HI
J Pharm Sci; 1993 May; 82(5):450-6. PubMed ID: 8360820
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and beta-blocking effects of transdermal timolol.
Kubota K; Yamada T; Kikuchi K; Koyama E; Ishizaki T
Eur J Clin Pharmacol; 1993; 44(5):493-5. PubMed ID: 8359190
[TBL] [Abstract][Full Text] [Related]
17. A novel differentiation method of vehicle models for topically applied drugs: application to a therapeutic timolol patch.
Kubota K; Yamada T; Ogura A; Ishizaki T
J Pharm Sci; 1990 Feb; 79(2):179-84. PubMed ID: 2324968
[TBL] [Abstract][Full Text] [Related]
18. Novel transdermal delivery of Timolol maleate using sugar esters: preclinical and clinical studies.
El-Laithy HM
Eur J Pharm Biopharm; 2009 May; 72(1):239-45. PubMed ID: 19126429
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study.
Morsi NM; Aboelwafa AA; Dawoud MHS
J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
